Banco Santander’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,244
Closed -$39.8K 459
2024
Q3
$39.8K Hold
1,244
﹤0.01% 443
2024
Q2
$102K Sell
1,244
-131
-10% -$14.2K ﹤0.01% 396
2024
Q1
$199K Buy
+1,375
New +$116K ﹤0.01% 405
2021
Q3
Sell
-862
Closed -$1.09M 412
2021
Q2
$1.09M Buy
+862
New +$973K 0.01% 257

Other funds holding CDLX

Banco Santander's CDLX Position: Q4 2024 in Review

Banco Santander sold out of Cardlytics (CDLX) in Q4 2024, closing a stake of 1,244 shares — an estimated $39.8K sold.

Banco Santander first reported a position in CDLX in Q2 2021 and held it in 4 quarters. The position peaked at $1.09M in Q2 2021. 108 funds tracked by Wall St. Rank hold CDLX as of Q4 2024.

  • Banco Santander reported no remaining Cardlytics position as of Q4 2024 after selling out during the quarter.
  • Banco Santander sold 1,244 Cardlytics shares in Q4 2024, an estimated $39.8K.
  • Banco Santander first reported a position in Cardlytics in Q2 2021 and held it in 4 quarters.
  • Banco Santander's Cardlytics position peaked at $1.09M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q4 2024.

Based on Banco Santander's 13F filing for Q4 2024, filed 7 Feb 2025.